12 reports

Its Cardiovascular and Neuromodulation Products segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases, as well as neuromodulation devices for the management of chronic pain and movemen

  • Point Of Care Testing
  • World
  • Forecast
  • Alere Inc.
  • Danaher Corporation

With increasing ageing population, the number of people suffering from chronic pain and infections is bound to increase because of their reduced quality of life and increased health care issues, who would look for better medical facilities for early detection of their disease.

  • Molecular Diagnostics
  • Point Of Care Testing
  • World
  • Market Size
  • Abbott Laboratories, Inc.

This segment also offers neuromodulation devices for the management of movement disorders and chronic pain.

  • Point Of Care Testing
  • World
  • Ascensia Diabetes Care
  • DexCom, Inc.
  • Medtronic, Inc.

In November 2017, the company announced the CE Mark for the Intellis (TM) platform for spinal cord stimulation (SCS) and peripheral nerve stimulation (PNS) as an aid in the management of certain types of chronic pain.

  • Point Of Care Testing
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Medtronic, Inc.
  • Sysmex Corporation
  • 15 KEY COMPANY PROFILES

This segment also offers neuromodulation devices for the management of movement disorders and chronic pain.

  • Point Of Care Testing
  • North America
  • United States
  • Alere Inc.
  • Danaher Corporation

Title Page No. ##.

  • Point Of Care Testing
  • World
  • Abbott
  • ARKRAY, Inc.
  • Bayer AG

Q. ##.

  • Diabetes
  • Point Of Care Testing
  • United States
  • Forecast
  • Biosensors International Group, Ltd.

CHRONIC PAIN IS DIFFICULT TO TREAT, BUT ONE POTENTIAL TREATMENT OPTION IS SPINAL CORD STIMULATION, OR SCS.

  • Diagnostics
  • Point Of Care Testing
  • North America
  • Forecast
  • Market Size

CHRONIC PAIN IS DIFFICULT TO TREAT, BUT ONE POTENTIAL TREATMENT OPTION IS SPINAL CORD STIMULATION, OR SCS.

  • Clinical Chemistry
  • Diagnostics
  • Hospital
  • In Vitro Diagnostic Reagent
  • Point Of Care Testing

Tanezumab (PF-##) -- In June 2017, Pfizer and Eli Lilly and Company (Lilly) announced that the FDA granted Fast Track designation for tanezumab for the treatment of chronic pain in patients with osteoarthritis and chronic low back pain.

  • Clinical Trial
  • Healthcare
  • Point Of Care Testing
  • United States
  • Pfizer Inc.

In Neuromodulation, strong double-digit growth was led by several recently launched products for the treatment of chronic pain and movement disorders.

  • Clinical Trial
  • Diagnostics
  • Infectious Disease
  • Point Of Care Testing
  • Grifols, S.A.

With increasing ageing population, the number of people suffering from chronic pain and infections is bound to increase because of their reduced quality of life and increased health care issues, who would look for better medical facilities for early detection of their disease.

  • In Vitro Diagnostics
  • Point Of Care Testing
  • World
  • Market Size
  • Roche Group